Canada Sepsis Diagnostics Market Size & Outlook, 2022-2030
Canada sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
Canada sepsis diagnostics market highlights
- The Canada sepsis diagnostics market generated a revenue of USD 60.3 million in 2022 and is expected to reach USD 114.6 million by 2030.
- The Canada market is expected to grow at a CAGR of 8.4% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 60.3 million |
| Market revenue in 2030 | USD 114.6 million |
| Growth rate | 8.4% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Canada accounted for 6.0% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 114.6 million by 2030.
Blood culture media was the largest segment with a revenue share of 38.97% in 2022. Horizon Databook has segmented the Canada sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The sepsis diagnostics market in Canada is witnessing robust growth, propelled by a combination of demographic trends, technological advancements, and healthcare policy initiatives.
According to Canadian Sepsis Foundation, 1 in 18 deaths is associated with sepsis, making it the 12th largest cause of death. The rate of Hospital-Acquired Infections (HAIs) in Canada is also increasing. This indicated that in 2022–2023, approximately 1 in every 17 hospitalized patients experienced unintended harm during their hospital stay.
Canadian healthcare authorities have been proactive in implementing guidelines and protocols for the early detection & management of sepsis. The Public Health Agency of Canada (PHAC) and other regulatory bodies are increasingly focusing on improving sepsis outcomes through awareness campaigns and education programs aimed at both healthcare professionals and the general public.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada sepsis diagnostics market size, by product, 2018-2030 (US$M)
Canada Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
